BACKGROUND AND OBJECTIVES: Calcification of the mitral and aortic valves is common in dialysis patients (CKD-5D). However, the prognostic significance of valvular calcification (VC) in CKD is not well established. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: 144 adult CKD-5D patients underwent bidimensional echocardiography for qualitative assessment of VC and cardiac computed tomography (CT) for quantification of coronary artery calcium (CAC) and VC. The patients were followed for a median of 5.6 years for mortality from all causes. RESULTS: Overall, 38.2% of patients had mitral VC and 44.4% had aortic VC on echocardiography. Patients with VC were older and less likely to be African American; all other characteristics were similar between groups. The mortality rate of patients with calcification of either valve was higher than for patients without VC. After adjustment for age, gender, race, diabetes mellitus, and history of atherosclerotic disease, only mitral VC remained independently associated with all-cause mortality (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.03 to 2.91). Patients with calcification of both valves had a two-fold increased risk of death during follow-up compared with patients without VC (HR, 2.16; 95% CI, 1.14 to 4.08). A combined CT score of VC and CAC was strongly associated with all-cause mortality during follow-up (HR for highest versus lowest tertile, 2.21; 95% CI, 1.08 to 4.54). CONCLUSIONS: VC is associated with a significantly increased risk for all-cause mortality in CKD-5D patients. These findings support the use of echocardiography for risk stratification in CKD-5D as recently suggested in the Kidney Disease Improving Global Outcomes guidelines.
BACKGROUND AND OBJECTIVES:Calcification of the mitral and aortic valves is common in dialysis patients (CKD-5D). However, the prognostic significance of valvular calcification (VC) in CKD is not well established. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: 144 adult CKD-5D patients underwent bidimensional echocardiography for qualitative assessment of VC and cardiac computed tomography (CT) for quantification of coronary artery calcium (CAC) and VC. The patients were followed for a median of 5.6 years for mortality from all causes. RESULTS: Overall, 38.2% of patients had mitral VC and 44.4% had aortic VC on echocardiography. Patients with VC were older and less likely to be African American; all other characteristics were similar between groups. The mortality rate of patients with calcification of either valve was higher than for patients without VC. After adjustment for age, gender, race, diabetes mellitus, and history of atherosclerotic disease, only mitral VC remained independently associated with all-cause mortality (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.03 to 2.91). Patients with calcification of both valves had a two-fold increased risk of death during follow-up compared with patients without VC (HR, 2.16; 95% CI, 1.14 to 4.08). A combined CT score of VC and CAC was strongly associated with all-cause mortality during follow-up (HR for highest versus lowest tertile, 2.21; 95% CI, 1.08 to 4.54). CONCLUSIONS: VC is associated with a significantly increased risk for all-cause mortality in CKD-5D patients. These findings support the use of echocardiography for risk stratification in CKD-5D as recently suggested in the Kidney Disease Improving Global Outcomes guidelines.
Authors: S Achenbach; D Ropers; S Möhlenkamp; A Schmermund; G Muschiol; J Groth; M Kusus; M Regenfus; W G Daniel; R Erbel; W Moshage Journal: Am J Cardiol Date: 2001-01-15 Impact factor: 2.778
Authors: Paolo Raggi; Amy Boulay; Scott Chasan-Taber; Naseem Amin; Maureen Dillon; Steven K Burke; Glenn M Chertow Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: Sharon M Moe; Kalisha D O'Neill; Danxia Duan; Sadiq Ahmed; Neal X Chen; Stephen B Leapman; Naomi Fineberg; Kenyon Kopecky Journal: Kidney Int Date: 2002-02 Impact factor: 10.612
Authors: Rajan Sharma; Denis Pellerin; David C Gaze; Rajnikant L Mehta; Helen Gregson; Christopher P Streather; Paul O Collinson; Stephen J D Brecker Journal: Atherosclerosis Date: 2006-05-02 Impact factor: 5.162
Authors: Caroline S Fox; Ramachandran S Vasan; Helen Parise; Daniel Levy; Christopher J O'Donnell; Ralph B D'Agostino; Emelia J Benjamin Journal: Circulation Date: 2003-03-25 Impact factor: 29.690
Authors: Angela Yee-Moon Wang; Mei Wang; Jean Woo; Christopher Wai-Kei Lam; Philip Kam-Tao Li; Siu-Fai Lui; John E Sanderson Journal: J Am Soc Nephrol Date: 2003-01 Impact factor: 10.121
Authors: Vincenzo Panuccio; Rocco Tripepi; Giovanni Tripepi; Francesca Mallamaci; Francesco A Benedetto; Alessandro Cataliotti; Ignazio Bellanuova; Giuseppe Giacone; Lorenzo S Malatino; Carmine Zoccali Journal: Am J Kidney Dis Date: 2004-03 Impact factor: 8.860
Authors: Il Young Kim; Min Jung Kim; Dong Won Lee; Soo Bong Lee; Min Ji Shin; Harin Rhee; Byeong Yun Yang; Sang Heon Song; Eun Young Seong; Ihm Soo Kwak Journal: Clin Exp Nephrol Date: 2015-03-12 Impact factor: 2.801
Authors: Luca Di Lullo; Antonio Gorini; Antonio Bellasi; Luigi F Morrone; Rodolfo Rivera; Luigi Russo; Alberto Santoboni; Domenico Russo Journal: Clin Kidney J Date: 2015-09-03